Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
We have now added a new section called the "Assay History List" to the "At A Gla...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...